CMO Analytical Method Transfer Risks and Mitigation

The first step in addressing analytical method transfer risks is recognizing the signals that indicate a problem. Symptoms can vary from atypical test results to increased deviation reports, but they…

How to Build a Sponsor Oversight Plan for Tech Transfer

Creating Effective Oversight Plans for CMO and CDMO Technology Transfers In today’s pharmaceutical landscape, the collaboration between sponsors and Contract Manufacturing Organizations (CMOs) or Contract Development and Manufacturing Organizations (CDMOs)…

CMO Raw Material and Supplier Alignment During Transfer

Identifying symptoms of raw material misalignment early can prevent more severe compliance breaches and inefficiencies further down the line. Key signals that practitioners and quality personnel should monitor include:Click to…

CMO Tech Transfer Risk Register Template

Identifying symptoms early in the tech transfer process is crucial in effectively managing risks. Here are common signals that indicate a problematic transfer:Click to read the full article.

How to Review CDMO Batch Records Before PPQ

Identifying clear signals or symptoms during batch record reviews is critical for the early detection of potential issues. Below are some common symptoms that professionals may encounter:Click to read the…

How to Review CDMO Batch Records Before PPQ

Identifying early warning signals is the first step in preemptively managing batch record issues. Symptoms can manifest in various ways, including:Click to read the full article.

CMO Packaging and Serialization Transfer Risks

Analyzing the Risks in CMO Packaging and Serialization Transfers The rise of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) has provided pharmaceutical companies with extensive outsourcing…